London
· Delayed Price · Currency is GBP · Price in EUR BioSenic Statistics
Total Valuation
BioSenic has a market cap or net worth of GBP 1.60 million. The enterprise value is 23.62 million.
| Market Cap | 1.60M |
| Enterprise Value | 23.62M |
Important Dates
The next estimated earnings date is Friday, April 25, 2025.
| Earnings Date | Apr 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | n/a |
| Shares Outstanding | n/a |
| Shares Change (YoY) | -5.94% |
| Shares Change (QoQ) | +30.85% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 327.95M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | n/a |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.74 |
| EV / Sales | 9.73 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -11.80 |
Financial Position
The company has a current ratio of 0.40
| Current Ratio | 0.40 |
| Quick Ratio | 0.33 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -11.34 |
| Interest Coverage | -0.64 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -22.77% |
| Return on Capital (ROIC) | -32.43% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.29 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.53% in the last 52 weeks. The beta is 0.22, so BioSenic's price volatility has been lower than the market average.
| Beta (5Y) | 0.22 |
| 52-Week Price Change | -88.53% |
| 50-Day Moving Average | 0.01 |
| 200-Day Moving Average | 0.01 |
| Relative Strength Index (RSI) | 41.13 |
| Average Volume (20 Days) | 1,494,115 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioSenic had revenue of GBP 2.43 million and -6.31 million in losses. Loss per share was -0.04.
| Revenue | 2.43M |
| Gross Profit | 2.43M |
| Operating Income | -3.06M |
| Pretax Income | -6.46M |
| Net Income | -6.31M |
| EBITDA | -2.85M |
| EBIT | -3.06M |
| Loss Per Share | -0.04 |
Balance Sheet
The company has 691,821 in cash and 22.72 million in debt, giving a net cash position of -22.02 million.
| Cash & Cash Equivalents | 691,821 |
| Total Debt | 22.72M |
| Net Cash | -22.02M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | -17.30M |
| Book Value Per Share | -0.07 |
| Working Capital | -3.30M |
Cash Flow
In the last 12 months, operating cash flow was -2.01 million and capital expenditures 10,174, giving a free cash flow of -2.00 million.
| Operating Cash Flow | -2.01M |
| Capital Expenditures | 10,174 |
| Free Cash Flow | -2.00M |
| FCF Per Share | n/a |
Margins
Gross margin is 100.00%, with operating and profit margins of -125.52% and -259.05%.
| Gross Margin | 100.00% |
| Operating Margin | -125.52% |
| Pretax Margin | -265.18% |
| Profit Margin | -259.05% |
| EBITDA Margin | -116.89% |
| EBIT Margin | -125.52% |
| FCF Margin | n/a |
Dividends & Yields
BioSenic does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.94% |
| Shareholder Yield | 5.94% |
| Earnings Yield | -394.13% |
| FCF Yield | -125.13% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
BioSenic has an Altman Z-Score of -6.45. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -6.45 |
| Piotroski F-Score | n/a |